+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer



Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer



Zhongguo Fei Ai Za Zhi 21(5): 413-418



【中文题目:中央型非小细胞肺癌立体定向放射治疗】 【中文摘要:已有的少数研究表明,早期不可手术非小细胞肺癌立体定向放射治疗肿瘤局控率可超过90%,患者中位生存时间和总生存率接近外科手术治疗。近年来立体定向放射治疗已成为I期不可手术周围型非小细胞肺癌患者的推荐治疗。但中央型肺癌因其解剖位置多毗邻纵隔内重要脏器,常可伴有更明显的放疗副反应。中央型肺癌是否能进行立体定向放射治疗目前尚无统一定论,本文主要对中央型非小细胞肺癌立体定向放射治疗的定义、适应症、剂量分割方式、危及器官剂量-体积限制、放疗技术支持、副反应及立体定向质子治疗进行综述。
】 【中文关键词:立体定向放射治疗;中央型;肺肿瘤】.

(PDF emailed within 0-6 h: $19.90)

Accession: 065534179

Download citation: RISBibTeXText

PMID: 29764593

DOI: 10.3779/j.issn.1009-3419.2018.05.10


Related references

Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer. Translational Lung Cancer Research 8(1): 58-69, 2019

Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis. Clinical Lung Cancer 2019, 2019

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry. Radiation Oncology 10: 113, 2016

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. Journal of Clinical Oncology 2019: Jco1800622, 2019

Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. Journal of Thoracic Oncology 10(4): 577-585, 2015

Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases. International Journal of Radiation Oncology, Biology, Physics 81(3): 856-862, 2011

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 72(4): 967-971, 2008

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). International Journal of Clinical Oncology 22(5): 849-856, 2017

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 80(4): 1015-1022, 2011

Stereotactic Body Radiation Therapy (SBRT) For Centrally Located Primary and Recurrent Non-Small Cell Lung Cancer: Analysis of Toxicity and Local Control. International Journal of Radiation Oncology*biology*physics 93(3): E418-E419, 2015

A case of severe hemoptysis after stereotactic body radiotherapy for peripherally located stage I non-small cell lung cancer. Japanese Journal of Radiology 33(6): 370-374, 2016

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*biology*physics 94(1): 5-6, 2016

The feasibility and efficacy of stereotactic body radiotherapy for centrally-located lung tumors. Anticancer Research 33(11): 4959-4964, 2014

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. RadioTherapy and Oncology 124(1): 11-17, 2017

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study. Oncology Letters 16(4): 4498-4506, 2018